# Opella Healthcare International SAS, Compiegne, France – FDA Inspections

Source: https://www.keypedia.com/companies/opella-healthcare-international-sas/53ed93ee-b631-49a0-bba2-a57194143394

> Inspection records and compliance data for Opella Healthcare International SAS in Compiegne. 6 FDA inspections on record, 1 Form 483, last inspected January 10, 2025.

---

## Details

- Name: Opella Healthcare International SAS
- FEI Number: 3003492806
- Address Line 1: 56 Route De Choisy
- City: Compiegne
- Country Name: France
- Address: 56 Route De Choisy, Compiegne, France
- Country: France

## Related Documents

- FDA Inspection 1268935 - Opella Healthcare International SAS - 2025-01-10 — source: FDA, date: January 10, 2025
- [FDA Inspection 1268935 - Opella Healthcare International SAS - 2025-01-10](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/b8697760-87bc-469f-8b6c-8f8d68e8c532) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 10, 2025
- FDA Inspection 1123990 - Opella Healthcare International SAS - 2019-10-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2019
- [FDA Inspection 1015497 - Opella Healthcare International SAS - 2017-06-23](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/1b0f4f62-7248-47ac-89a2-45df0bbf81a3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 23, 2017
- [FDA Inspection 946883 - Opella Healthcare International SAS - 2015-09-18](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/e8f8ad70-e8e2-4f7d-b190-d3a9600b2da0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2015
- FDA Inspection 853427 - Opella Healthcare International SAS - 2013-09-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2013
- [FDA Inspection 754638 - Opella Healthcare International SAS - 2011-10-21](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/6acc8514-a9b1-4dae-b00c-9d276858f948) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2011

## Related Companies

- [R-Pharm Germany GmbH](https://www.keypedia.com/companies/r-pharm-germany-gmbh/00237a65-957b-4892-abce-2844ed37acda)
- [Boehringer Ingelheim Espana S.A.](https://www.keypedia.com/companies/boehringer-ingelheim-espana-sa/afd6c8fe-92cc-4db4-8157-94020bcf06d6)
- [Zydus Hospira Oncology Private Ltd.](https://www.keypedia.com/companies/zydus-hospira-oncology-private-ltd/1daf2047-24d1-4343-9500-8a3c69eccaf4)
- [ANSTO Nuclear Medicine](https://www.keypedia.com/companies/ansto-nuclear-medicine/9bb26b43-b1c1-4d57-9008-7563e01d67e2)
- [EirGen Pharma Ltd](https://www.keypedia.com/companies/eirgen-pharma-ltd/f9a682ae-b665-4341-814c-af610c74a3ec)
- [Visum Pharmaceutical Co Ltd](https://www.keypedia.com/companies/visum-pharmaceutical-co-ltd/304efe69-24b4-4b93-aece-f7addcc5e21c)
- [Citragen Pharmaceuticals Inc](https://www.keypedia.com/companies/citragen-pharmaceuticals-inc/c9428b65-fa89-4165-8df5-4b2ae89afc03)
- [Polygen Pharmaceuticals Inc.](https://www.keypedia.com/companies/polygen-pharmaceuticals-inc/d7df0d1f-787a-4629-b096-255e664d26ef)
- [Sofgen Pharmaceuticals LLC](https://www.keypedia.com/companies/sofgen-pharmaceuticals-llc/4bf867c1-4886-43a8-b3a1-3d027c2307b8)
- [CorePharma, LLC](https://www.keypedia.com/companies/corepharma-llc/037e485c-5d38-40e3-80fe-b00a72cda489)